X-linked agammaglobulinemia

Clinical trials for X-linked agammaglobulinemia explained in plain language.

Never miss a new study

Get alerted when new X-linked agammaglobulinemia trials appear

Sign up with your email to follow new studies for X-linked agammaglobulinemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1

New IVIG aims to slash infection risk for immune-deficient patients

Disease control Not yet recruiting

This study tests a new medicine called Boya IVIG in 50 people with primary immunodeficiency (CVID or XLA), a condition where the body can't fight infections well. Participants get the drug every 21 or 28 days for a year to see if it keeps serious bacterial infections below one pe…

Matched conditions: X-LINKED AGAMMAGLOBULINEMIA

Phase 3 • Sponsor: Azidus Brasil • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

X-linked agammaglobulinemia

Get alerted when new X-linked agammaglobulinemia trials appear

New IVIG aims to slash infection risk for immune-deficient patients